GSK — GSK Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapSuper Stock

Annual income statement for GSK, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	R2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	24,354	24,696	29,324	30,328	31,376
Cost of Revenue
Gross Profit	17,033	16,690	20,857	21,965	22,559
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	18,375	20,375	22,891	23,582	27,349
Operating Profit	5,979	4,321	6,433	6,746	4,027
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5,170	3,599	5,628	6,064	3,477
Provision for Income Taxes
Net Income After Taxes	5,103	3,516	4,921	5,308	2,951
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	5,749	4,385	14,956	4,928	2,575
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	5,749	4,385	14,956	4,928	2,575
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.789	0.681	1.14	1.4	1.13
Dividends per Share